Schedule 13G ownership disclosure
SCILEX HOLDING CO
Common Stock par value $0.0001 per share · CUSIP: 80880W106
Event date: 2025-01-13
- Filing-level shares
- 15,500,000.00
- Percent of class
- 6.2%
- Oramed Pharmaceuticals Inc.
Shares: 15,500,000.00 · Class: 6.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-004622
- Form type
- SCHEDULE 13G
- Filer
- ORAMED PHARMACEUTICALS INC.
- CIK
- CIK 1176309
- Filed
- Jan 17, 2025
- Reporting period
- Jan 13, 2025
- Description
- Schedule 13G beneficial ownership